Log In
BCIQ
Print this Print this
 

Norketotifen

  Manage Alerts
Collapse Summary General Information
Company Sirion Therapeutics Inc.
DescriptionActive metabolite of undisclosed marketed ocular antihistamine
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAllergy
Indication DetailsTreat allergy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today